Advertisement
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-ERK Signaling

Shu Li, Qinglan Wang, Yanyan Tao and Chenghai Liu
Journal of Pharmacology and Experimental Therapeutics August 19, 2016, jpet.116.234179; DOI: https://doi.org/10.1124/jpet.116.234179

Article Information

jpet.116.234179
DOI 
https://doi.org/10.1124/jpet.116.234179
PubMed 
27543328
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online August 19, 2016.

Article Versions

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Shu Li1,
  2. Qinglan Wang2,
  3. Yanyan Tao2,*, and
  4. Chenghai Liu2
  1. 1 Shuguang Hospital Affiliated to Shanghai University of Traditional Chin;
  2. 2 Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chin
  1. ↵*Address correspondence to: taoyanyan1023{at}126.com

Statistics from Altmetric.com

Article usage

Article usage: August 2016 to December 2024

AbstractFullPdf
Aug 2016139182
Sep 2016100582
Oct 20161963431
Nov 2016781614
Dec 201660618
Jan 201731639
Feb 2017491142
Mar 201738437
Apr 201726624
May 201741238
Jun 201737433
Jul 201730117
Aug 201731211
Sep 20173608
Oct 20174178
Nov 201783338
Dec 2017515817
Jan 2018102909
Feb 2018189415
Mar 2018721314
Apr 20182459
May 201862111
Jun 20181788
Jul 20184567
Aug 201837017
Sep 201832016
Oct 20183454
Nov 201866622
Dec 20181458
Jan 20191314
Feb 201913710
Mar 201912616
Apr 2019096
May 20191158
Jun 20191217
Jul 201922421
Aug 20190148
Sep 20190118
Oct 201902217
Nov 201921912
Dec 201971515
Jan 202002113
Feb 202002811
Mar 20203308
Apr 20200237
May 20200199
Jun 2020084
Jul 20200142
Aug 20201185
Sep 202031611
Oct 20201155
Nov 2020177
Dec 202031514
Jan 20213917
Feb 202111312
Mar 202192811
Apr 2021592
May 20212347
Jun 20213165
Jul 202104614
Aug 202122811
Sep 202111112
Oct 202101029
Nov 202111823
Dec 202121516
Jan 20222717
Feb 20223108
Mar 202211114
Apr 202211014
May 20222710
Jun 2022196
Jul 20225167
Aug 2022262
Sep 202221722
Oct 20221623
Nov 20223510
Dec 20223136
Jan 20231810
Feb 20232310
Mar 20231711
Apr 20231513
May 20233511
Jun 20232710
Jul 2023710
Aug 20232430
Sep 20231300
Oct 20232717
Nov 20231210
Dec 20232510
Jan 20242020
Feb 20241739
Mar 20249711
Apr 20244063
May 20242411
Jun 20244114
Jul 20242815
Aug 20243503
Sep 20245701
Oct 20242800
Nov 20241401
Dec 20242100

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-ERK Signaling

Shu Li, Qinglan Wang, Yanyan Tao and Chenghai Liu
Journal of Pharmacology and Experimental Therapeutics August 19, 2016, jpet.116.234179; DOI: https://doi.org/10.1124/jpet.116.234179
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement